Gene · 3735
Papers1,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combinational antibody detection approach increases the clinical validity of colorectal cancer screening. | J Clin Lab Anal | 2023 | 37964630 | PubTator, text mining | PubMed |
| HIV-1 Nef Changes the Proteome of T Cells Extracellular Vesicles Depleting IFITMs and Other Antiviral Factors. | Mol Cell Proteomics | 2023 | 37940003 | PubTator, text mining | PubMed |
| Human lysyl-tRNA synthetase phosphorylation promotes HIV-1 proviral DNA transcription. | Nucleic Acids Res | 2023 | 37933844 | PubTator, text mining | PubMed |
| Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals. | Eur J Med Res | 2023 | 37924162 | PubTator, text mining | PubMed |
| Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations. | J Clin Immunol | 2023 | 37921915 | PubTator, text mining | PubMed |
| Combined Presence in Heterozygosis of Two Variant Usher Syndrome Genes in Two Siblings Affected by Isolated Profound Age-Related Hearing Loss. | Biomedicines | 2023 | 37893031 | PubTator, text mining | PubMed |
| Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis. | Metabolites | 2023 | 37887389 | PubTator, text mining | PubMed |
| Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy. | Diagn Pathol | 2023 | 37865792 | PubTator, text mining | PubMed |
| Clinical and biological significance of circulating miRNAs in chronic pancreatitis patients undergoing total pancreatectomy with islet autotransplantation. | Clin Transl Med | 2023 | 37846205 | PubTator, text mining | PubMed |
| A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma. | Front Pharmacol | 2023 | 37822882 | PubTator, text mining | PubMed |
| Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor. | Front Pharmacol | 2023 | 37808191 | PubTator, text mining | PubMed |
| The characterization of RNA-binding proteins and RNA metabolism-related proteins in fungal extracellular vesicles. | Front Cell Infect Microbiol | 2023 | 37780856 | PubTator, text mining | PubMed |
| Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease. | Exp Mol Med | 2023 | 37779151 | PubTator, text mining | PubMed |
| Antibody Deficiency in Patients with Biallelic KARS1 Mutations. | J Clin Immunol | 2023 | 37770806 | PubTator, text mining | PubMed |
| Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer. | Front Med (Lausanne) | 2023 | 37720505 | PubTator, text mining | PubMed |
| CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer. | Cell Death Dis | 2023 | 37716979 | PubTator, text mining | PubMed |
| Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. | Thorac Cancer | 2023 | 37704455 | PubTator, text mining | PubMed |
| Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. | Front Immunol | 2023 | 37701440 | PubTator, text mining | PubMed |
| Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value. | World J Gastroenterol | 2023 | 37701134 | PubTator, text mining | PubMed |
| Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers. | J Gastroenterol | 2023 | 37698719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3735/papers?page=5